Publisher Tronc Names CEO Dearborn Chairman of Board - NBC4 Washington
National & International News
The day’s top national and international news

Publisher Tronc Names CEO Dearborn Chairman of Board

Dearborn replaces Michael Ferro, who is retiring

    processing...

    NEWSLETTERS

    Sentara Treats Man's Chronic Wounds
    AP
    A news stand display copies of the Daily News, Tuesday Sept. 5, 2017, in New York. The tabloid newspaper has been acquired by Tronc, the publisher of the Los Angeles Times and The Chicago Tribune.

    Newspaper publisher Tronc has named CEO Justin Dearborn as its chairman of the board, replacing Michael Ferro, who is retiring.

    The change announced Monday shortly before Fortune magazine published a story about two women who allege that Ferro made unwanted sexual advances during 2013 and 2016 before he become Tronc's chairman.

    "Michael Ferro has had no claims filed against him while leading Tronc as chairman," Tronc said in a statement. "Further, we are aware of no claims filed against Mr. Ferro throughout his career. As Mr. Ferro has retired after leading a financial turnaround of Tronc, we wish him well in his private life and will have no further comment."

    Ferro struck it rich as an entrepreneur involved in two startups that were sold for more than $1 billion. In 2016, he bought a stake in the Tribune Co, which was subsequently renamed as Tronc.

    Chicago-based Tronc Inc., which operates newspapers including the Chicago Tribune, New York Daily News and The Baltimore Sun, announced last month it had sold the Los Angeles Times and other papers for $500 million and an additional $90 million in pension benefits.

    "Michael retires having created considerable shareholder value for the company in just two years as chairman of the board," Dearborn said, adding that the company had tripled its market capitalization, quadrupled its cash holdings and reduced its debt under Ferro's leadership.

    Dearborn was appointed CEO of Tronc in February 2016. He previously led Merge Healthcare until its acquisition by IBM for $1 billion in October 2015.

    FDA to Consider Marijuana-Derived Medication for Children

    [NATL] FDA to Consider Marijuana-Derived Medication for Children
    A marijuana-based treatment for severe forms of pediatric epilepsy is a step closer to approval by the Food and Drug Administration. FDA advisors voted Thursday to recommend approval for the drug that's been hailed as a "breakthrough," saying the cannabis-based oil has clear benefits for children with uncontrollable seizures. 
    (Published 11 minutes ago)